Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 176

1.

Human papillomavirus distribution in invasive cervical carcinoma in sub-Saharan Africa: could HIV explain the differences?

Ndiaye C, Alemany L, Ndiaye N, Kamaté B, Diop Y, Odida M, Banjo K, Tous S, Klaustermeier JE, Clavero O, Castellsagué X, Bosch FX, Trottier H, de Sanjosé S.

Trop Med Int Health. 2012 Dec;17(12):1432-40. doi: 10.1111/tmi.12004. Epub 2012 Oct 29.

2.

Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa.

Denny L, Adewole I, Anorlu R, Dreyer G, Moodley M, Smith T, Snyman L, Wiredu E, Molijn A, Quint W, Ramakrishnan G, Schmidt J.

Int J Cancer. 2014 Mar 15;134(6):1389-98. doi: 10.1002/ijc.28425. Epub 2013 Nov 14.

3.

Human papillomavirus prevalence and type-specific relative contribution in invasive cervical cancer specimens from Italy.

Mariani L, Monfulleda N, Alemany L, Vizza E, Marandino F, Vocaturo A, Benevolo M, Quirós B, Lloveras B, Klaustermeier JE, Quint W, de Sanjosé S, Bosch FX.

BMC Cancer. 2010 Jun 4;10:259. doi: 10.1186/1471-2407-10-259.

4.

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.

de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin HR, Vallejos CS, de Ruiz PA, Lima MA, Guimera N, Clavero O, Alejo M, Llombart-Bosch A, Cheng-Yang C, Tatti SA, Kasamatsu E, Iljazovic E, Odida M, Prado R, Seoud M, Grce M, Usubutun A, Jain A, Suarez GA, Lombardi LE, Banjo A, Menéndez C, Domingo EJ, Velasco J, Nessa A, Chichareon SC, Qiao YL, Lerma E, Garland SM, Sasagawa T, Ferrera A, Hammouda D, Mariani L, Pelayo A, Steiner I, Oliva E, Meijer CJ, Al-Jassar WF, Cruz E, Wright TC, Puras A, Llave CL, Tzardi M, Agorastos T, Garcia-Barriola V, Clavel C, Ordi J, Andújar M, Castellsagué X, Sánchez GI, Nowakowski AM, Bornstein J, Muñoz N, Bosch FX; Retrospective International Survey and HPV Time Trends Study Group.

Lancet Oncol. 2010 Nov;11(11):1048-56. doi: 10.1016/S1470-2045(10)70230-8. Epub 2010 Oct 15.

PMID:
20952254
5.

Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States.

Wheeler CM, Hunt WC, Joste NE, Key CR, Quint WG, Castle PE.

J Natl Cancer Inst. 2009 Apr 1;101(7):475-87. doi: 10.1093/jnci/djn510. Epub 2009 Mar 24.

6.

Prevalence and distribution of high-risk human papillomavirus genotypes in invasive carcinoma of the uterine cervix in Uruguay.

Berois N, De Cremoux P, Mazal D, Sica A, Cedeira M, Caserta B, Barrios E, Osinaga E, Sastre-Garau X.

Int J Gynecol Cancer. 2013 Mar;23(3):527-32. doi: 10.1097/IGC.0b013e318285e753.

PMID:
23392403
7.

Effect of HIV Infection on Human Papillomavirus Types Causing Invasive Cervical Cancer in Africa.

Clifford GM, de Vuyst H, Tenet V, Plummer M, Tully S, Franceschi S.

J Acquir Immune Defic Syndr. 2016 Nov 1;73(3):332-339.

8.

Epidemiology and prevention of human papillomavirus and cervical cancer in sub-Saharan Africa: a comprehensive review.

Louie KS, de Sanjose S, Mayaud P.

Trop Med Int Health. 2009 Oct;14(10):1287-302. doi: 10.1111/j.1365-3156.2009.02372.x. Review.

9.

Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada.

Coutlée F, Ratnam S, Ramanakumar AV, Insinga RR, Bentley J, Escott N, Ghatage P, Koushik A, Ferenczy A, Franco EL.

J Med Virol. 2011 Jun;83(6):1034-41. doi: 10.1002/jmv.22081.

PMID:
21503917
10.

Human papillomavirus types in invasive cervical cancer specimens from Turkey.

Usubütün A, Alemany L, Küçükali T, Ayhan A, Yüce K, de Sanjosé S, Font R, Lloveras B, Klaustermeier J, Quint W, Muñoz N, Bosch FX.

Int J Gynecol Pathol. 2009 Nov;28(6):541-8. doi: 10.1097/PGP.0b013e3181aaba0d.

PMID:
19851201
11.

HPV genotyping in cervical cancer in Northern Thailand: adapting the linear array HPV assay for use on paraffin-embedded tissue.

Siriaunkgul S, Suwiwat S, Settakorn J, Khunamornpong S, Tungsinmunkong K, Boonthum A, Chaisuksunt V, Lekawanvijit S, Srisomboon J, Thorner PS.

Gynecol Oncol. 2008 Mar;108(3):555-60. doi: 10.1016/j.ygyno.2007.11.016. Epub 2008 Jan 15.

PMID:
18199473
12.

Human papillomavirus in invasive cervical cancer and cervical intraepithelial neoplasia 2 and 3 in Venezuela: a cross-sectional study.

Sánchez-Lander J, Cortiñas P, Loureiro CL, Pujol FH, Medina F, Capote-Negrín L, Bianchi G, García-Barriola V, Ruiz-Benni A, Avilán-Rovira J, Acosta H.

Cancer Epidemiol. 2012 Oct;36(5):e284-7. doi: 10.1016/j.canep.2012.04.005. Epub 2012 May 17.

PMID:
22608058
13.

Human papillomavirus genotype distribution in cervical cancer cases in Spain. Implications for prevention.

Alemany L, Pérez C, Tous S, Llombart-Bosch A, Lloveras B, Lerma E, Guarch R, Andújar M, Pelayo A, Alejo M, Ordi J, Klaustermeier J, Velasco J, Guimerà N, Clavero O, Castellsagué X, Quint W, Muñoz N, Bosch FX, de Sanjosé S; Spanish study group RIS HPV TT.

Gynecol Oncol. 2012 Mar;124(3):512-7. doi: 10.1016/j.ygyno.2011.11.024. Epub 2011 Nov 23.

PMID:
22119990
14.

Human Papillomavirus type distribution in invasive cervical cancer in Uganda.

Odida M, de Sanjosé S, Quint W, Bosch XF, Klaustermeier J, Weiderpass E.

BMC Infect Dis. 2008 Jun 24;8:85. doi: 10.1186/1471-2334-8-85.

15.

Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical intraepithelial neoplasia across 5 countries in Asia.

Quek SC, Lim BK, Domingo E, Soon R, Park JS, Vu TN, Tay EH, Le QT, Kim YT, Vu BQ, Cao NT, Limson G, Pham VT, Molijn A, Ramakrishnan G, Chen J.

Int J Gynecol Cancer. 2013 Jan;23(1):148-56. doi: 10.1097/IGC.0b013e31827670fd.

PMID:
23221730
16.

Human papillomavirus type distribution in cervical intraepithelial neoplasia grade 2/3 and cervical cancer in Portugal: a CLEOPATRE II Study.

Pista A, de Oliveira CF, Lopes C, Cunha MJ; CLEOPATRE Portugal Study Groupa.

Int J Gynecol Cancer. 2013 Mar;23(3):500-6. doi: 10.1097/IGC.0b013e318280f26e.

PMID:
23392401
17.

Human papillomavirus genotype distribution in invasive cervical cancer in Bosnia and Herzegovina.

Iljazović E, Mena M, Tous S, Alemany L, Omeragić F, Sadiković A, Clavero O, Vergara M, Bosch FX, de Sanjosé S.

Cancer Epidemiol. 2014 Oct;38(5):504-10. doi: 10.1016/j.canep.2014.06.004. Epub 2014 Aug 11.

PMID:
25130915
18.

Type-specific human papillomavirus distribution in invasive cervical carcinomas in Paraguay. A study of 432 cases.

Kasamatsu E, Cubilla AL, Alemany L, Chaux A, Tous S, Mendoza L, Paez M, Klaustermeier JE, Quint W, Lloveras B, de Sanjose S, Muñoz N, Bosch FX.

J Med Virol. 2012 Oct;84(10):1628-35. doi: 10.1002/jmv.23373.

PMID:
22930512
19.

Human papillomavirus genotype distribution and human papillomavirus 16 and human papillomavirus 18 genomic integration in invasive and in situ cervical carcinoma in human immunodeficiency virus-infected women.

Darwich L, Cañadas MP, Sirera G, Alameda F, Forcada P, Delas J, Fernández I, Llatjós M, Coll J, Clotet B, Videla S.

Int J Gynecol Cancer. 2011 Nov;21(8):1486-90. doi: 10.1097/IGC.0b013e31822a0195.

PMID:
21892092
20.

Molecular detection and genotyping of human papillomavirus in cervical carcinoma biopsies in an area of high incidence of cancer from Moroccan women.

Khair MM, Mzibri ME, Mhand RA, Benider A, Benchekroun N, Fahime EM, Benchekroun MN, Ennaji MM.

J Med Virol. 2009 Apr;81(4):678-84. doi: 10.1002/jmv.21279.

PMID:
19235879

Supplemental Content

Support Center